Zongran Pang

411 total citations
24 papers, 302 citations indexed

About

Zongran Pang is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Zongran Pang has authored 24 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Physiology. Recurrent topics in Zongran Pang's work include Metabolism, Diabetes, and Cancer (4 papers), Diet, Metabolism, and Disease (3 papers) and RNA modifications and cancer (3 papers). Zongran Pang is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Diet, Metabolism, and Disease (3 papers) and RNA modifications and cancer (3 papers). Zongran Pang collaborates with scholars based in China. Zongran Pang's co-authors include Binan Lu, Zhao Zhang, Shifeng Chu, Yantao Yang, Nai‐Hong Chen, Qingshan Liu, Xiaoying Yin, Yinjiang Zhang, Yuzhou Pang and He Xu and has published in prestigious journals such as Journal of Ethnopharmacology, International Journal of Biological Macromolecules and Frontiers in Pharmacology.

In The Last Decade

Zongran Pang

23 papers receiving 301 citations

Peers

Zongran Pang
Seung Hyo Jung South Korea
Peipei Yuan China
Wenjiang Cao China
Eman A. Mohamed Egypt
Yilixiati Xiaokaiti China
Yingwen Zhang China
Tays Amanda Felisberto Gonçalves Brazil
Yuyang Wang China
Ayman A. Soubh Egypt
Seung Hyo Jung South Korea
Zongran Pang
Citations per year, relative to Zongran Pang Zongran Pang (= 1×) peers Seung Hyo Jung

Countries citing papers authored by Zongran Pang

Since Specialization
Citations

This map shows the geographic impact of Zongran Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongran Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongran Pang more than expected).

Fields of papers citing papers by Zongran Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongran Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongran Pang. The network helps show where Zongran Pang may publish in the future.

Co-authorship network of co-authors of Zongran Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Zongran Pang. A scholar is included among the top collaborators of Zongran Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongran Pang. Zongran Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Haiying, et al.. (2025). Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics. Journal of Ethnopharmacology. 351. 120136–120136.
2.
Liu, Pengxin, Xin Pan, Mi Huang, et al.. (2025). Downregulation of collagen IV deposition and ITGB1-FAK signaling pathway to inhibit adipogenesis: A novel mechanism of swertiamarin in treating type 2 diabetes mellitus. International Journal of Biological Macromolecules. 299. 140048–140048. 6 indexed citations
3.
Xue, JunShuai, Lulu Chen, Xiaobin Song, et al.. (2025). Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening. Frontiers in Chemistry. 13. 1548812–1548812. 1 indexed citations
4.
He, Xu, Wei Zhao, Ping Li, et al.. (2025). Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus. Frontiers in Pharmacology. 15. 1483792–1483792. 4 indexed citations
5.
Yang, Chen, Xin Pan, Wenqi Liu, et al.. (2023). Black mulberry extract inhibits hepatic adipogenesis through AMPK/mTOR signaling pathway in T2DM mice. Journal of Ethnopharmacology. 319(Pt 2). 117216–117216. 13 indexed citations
6.
Zhao, Ziqi, Yixin Ren, Wei Hong, et al.. (2023). Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects. Bioorganic & Medicinal Chemistry. 92. 117436–117436. 6 indexed citations
7.
Tian, Yu, et al.. (2023). The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK/PGC-1α/PPARα pathway. Diabetology & Metabolic Syndrome. 15(1). 145–145. 4 indexed citations
8.
9.
Zhang, Yinjiang, et al.. (2022). Ferroptosis-related differentially expressed genes serve as new biomarkers in ischemic stroke and identification of therapeutic drugs. Frontiers in Nutrition. 9. 1010918–1010918. 4 indexed citations
10.
Zhou, Lu, et al.. (2022). Portulaca oleracea alleviates CCl4-induced acute liver injury by regulating hepatic S100A8 and S100A9. Chinese Herbal Medicines. 15(1). 110–116. 11 indexed citations
11.
Fan, Lu, et al.. (2022). Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway. Biomedicine & Pharmacotherapy. 148. 112697–112697. 11 indexed citations
12.
13.
Zhang, Yuxin, Xing Wang, Binan Lu, et al.. (2021). Functional and binding studies of gallic acid showing platelet aggregation inhibitory effect as a thrombin inhibitor. Chinese Herbal Medicines. 14(2). 303–309. 23 indexed citations
14.
Lu, Binan, et al.. (2021). Hypoglycemic effects of Tibetan medicine Huidouba in STZ-induced diabetic mice and db/db mice. Chinese Herbal Medicines. 13(2). 202–209. 16 indexed citations
15.
Chu, Shifeng, et al.. (2021). Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders. Frontiers in Pharmacology. 12. 671734–671734. 58 indexed citations
16.
Zhang, Yinjiang, Hongyun Wei, Mingyan Fang, et al.. (2021). CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment. Frontiers in Cell and Developmental Biology. 9. 27 indexed citations
17.
Xia, Meng, Lijun Duan, Binan Lu, Yuzhou Pang, & Zongran Pang. (2021). LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells. Chinese Medical Journal. 134(17). 2091–2101. 11 indexed citations
18.
Lu, Binan, et al.. (2020). Huidouba Improved Podocyte Injury by Down-Regulating Nox4 Expression in Rats With Diabetic Nephropathy. Frontiers in Pharmacology. 11. 587995–587995. 20 indexed citations
19.
Huang, An, Gang Fang, Yuzhou Pang, & Zongran Pang. (2019). A Network Pharmacology Approach to Explore Mechanism of Action of Longzuan Tongbi Formula on Rheumatoid Arthritis. Evidence-based Complementary and Alternative Medicine. 2019. 1–13. 14 indexed citations
20.
Liu, Qingshan, Zongran Pang, Rui Liu, et al.. (2011). Effective compounds group of Mongolian prescriptions BAIMAI-SAN protect against peripheral neuropathy in lower limbs of rats through neuro protective effect. Journal of Ethnopharmacology. 135(3). 786–791. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seung Hyo Jung Breakdown of academic impact, for papers by Peipei Yuan Breakdown of academic impact, for papers by Wenjiang Cao Breakdown of academic impact, for papers by Eman A. Mohamed Breakdown of academic impact, for papers by Yilixiati Xiaokaiti Breakdown of academic impact, for papers by Yingwen Zhang Breakdown of academic impact, for papers by Tays Amanda Felisberto Gonçalves Breakdown of academic impact, for papers by Yuyang Wang Breakdown of academic impact, for papers by Ayman A. Soubh
Rankless by CCL
2026